Ignyte Acquisition Correlations
| PKBODelisted Stock | USD 1.31 0.09 6.43% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ignyte Acquisition moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ignyte Acquisition Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Ignyte Acquisition Correlation With Market
Good diversification
The correlation between Ignyte Acquisition Corp and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ignyte Acquisition Corp and DJI in the same portfolio, assuming nothing else is changed.
Ignyte |
The ability to find closely correlated positions to Ignyte Acquisition could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ignyte Acquisition when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ignyte Acquisition - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ignyte Acquisition Corp to buy it.
Moving together with Ignyte Pink Sheet
| 0.62 | DTIL | Precision BioSciences | PairCorr |
| 0.66 | VINC | Vincerx Pharma | PairCorr |
| 0.77 | EDSA | Edesa Biotech Fiscal Year End 20th of December 2024 | PairCorr |
Moving against Ignyte Pink Sheet
| 0.75 | VAXX | Vaxxinity | PairCorr |
| 0.75 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.7 | VANI | Vivani Medical | PairCorr |
| 0.52 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.51 | VCYT | Veracyte | PairCorr |
| 0.48 | VERA | Vera Therapeutics | PairCorr |
| 0.41 | DSGN | Design Therapeutics | PairCorr |
| 0.35 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.8 | ELDN | Eledon Pharmaceuticals | PairCorr |
| 0.79 | VYNE | Vyne Therapeutics | PairCorr |
| 0.72 | ENSC | Ensysce Biosciences | PairCorr |
| 0.69 | VSTM | Verastem | PairCorr |
| 0.62 | VRNA | Verona Pharma PLC | PairCorr |
| 0.6 | ENTO | Entero Therapeutics, Symbol Change | PairCorr |
| 0.57 | ENGN | enGene Holdings Common | PairCorr |
| 0.39 | ELVN | Enliven Therapeutics | PairCorr |
| 0.36 | VTVT | vTv Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ignyte Pink Sheet performing well and Ignyte Acquisition Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ignyte Acquisition's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AKESF | 3.98 | 0.85 | 0.12 | (7.74) | 3.85 | 12.00 | 41.83 | |||
| IVBT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ADYX | 6.52 | 1.93 | 0.00 | (0.13) | 0.00 | 0.00 | 266.67 | |||
| ASCLF | 1.26 | 0.29 | 0.00 | 0.90 | 0.00 | 0.00 | 33.04 | |||
| AVXT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MOLN | 4.73 | (0.11) | (0.02) | 0.00 | 5.15 | 9.61 | 52.92 | |||
| MNOV | 5.00 | 1.29 | 0.18 | (0.44) | 4.13 | 14.50 | 61.30 | |||
| ANEB | 5.22 | (0.27) | 0.00 | (0.04) | 0.00 | 8.85 | 76.00 | |||
| CSBR | 3.29 | 0.04 | (0.02) | (0.08) | 3.87 | 6.23 | 22.49 |
Ignyte Acquisition Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ignyte Acquisition pink sheet to make a market-neutral strategy. Peer analysis of Ignyte Acquisition could also be used in its relative valuation, which is a method of valuing Ignyte Acquisition by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Still Interested in Ignyte Acquisition Corp?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.